About
glpletter
A blog and newsletter on Intranasal and nose-to-brain drug delivery science, GLP-1 biology, therapeutics, and market landscape, and Nanoparticle and nanomedicine technology fundamentals.
What we cover
Contributors
- Andre Nair · Columnist
- Elias Kowalski · Editor at Large
- Kai Mbeki · Senior Writer
- Kai Park · Editor at Large
- Lucia Nair · Staff Writer
- Nico Bergström · Columnist
- Priya Rossi · Features Editor